Pacer Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-116,661
Closed -$1.89M 3552
2023
Q1
$1.89M Buy
116,661
+43,555
+60% +$820K 0.01% 728
2022
Q4
$1.29M Buy
73,106
+15,750
+27% +$313K 0.01% 709
2022
Q3
$1.12M Buy
+57,356
New +$1.22M 0.01% 517
2021
Q4
Sell
-34,881
Closed -$937K 2215
2021
Q3
$937K Buy
+34,881
New +$1M 0.01% 906
2020
Q2
Sell
-1,620
Closed -$54K 979
2020
Q1
$54K Sell
1,620
-4,739
-75% -$124K ﹤0.01% 542
2019
Q4
$150K Buy
6,359
+1,321
+26% +$29.6K 0.01% 1133
2019
Q3
$91K Sell
5,038
-4,657
-48% -$76.9K ﹤0.01% 1125
2019
Q2
$152K Buy
9,695
+2,998
+45% +$59K ﹤0.01% 1075
2019
Q1
$153K Buy
6,697
+1,063
+19% +$24K ﹤0.01% 662
2018
Q4
$131K Buy
5,634
+2,829
+101% +$75.5K ﹤0.01% 231
2018
Q3
$93K Buy
+2,805
New +$105K ﹤0.01% 1099

Other funds holding PETS

Pacer Advisors's PETS Position: Q2 2023 in Review

Pacer Advisors sold out of PetMed Express (PETS) in Q2 2023, closing a stake of 116,661 shares — an estimated $1.89M sold.

Pacer Advisors first reported a position in PETS in Q3 2018 and held it in 11 quarters. The position peaked at $1.89M in Q1 2023. 149 funds tracked by Wall St. Rank hold PETS as of Q2 2023.

  • Pacer Advisors reported no remaining PetMed Express position as of Q2 2023 after selling out during the quarter.
  • Pacer Advisors sold 116,661 PetMed Express shares in Q2 2023, an estimated $1.89M.
  • Pacer Advisors first reported a position in PetMed Express in Q3 2018 and held it in 11 quarters.
  • Pacer Advisors's PetMed Express position peaked at $1.89M in Q1 2023.
  • 149 funds tracked by Wall St. Rank held PetMed Express as of Q2 2023.

Based on Pacer Advisors's 13F filing for Q2 2023, filed 12 Jul 2023.